Day: September 21, 2022

Homestead, FL., Sept. 21, 2022 (GLOBE NEWSWIRE) — BlueFire Equipment, Corp. (OTC: BLFR) (“BLFR” or “the Company”), a company specializing in emerging industries acquisitions with an emphasis in the business of agriculture, submits company name and ticker change for its new direction in the agriculture market after acquiring Miracle Life Farm, LLC. announced on September 15, 2022. The Company is in process to change the Company’s name to Farmies, Inc. and its ticker symbol to MIES. The change was made to best suit the Company’s new direction in the Agriculture market currently valued to be $12.5 billion for the year 2022 at a compound annual growth rate of 11.1% as part of its restructure. Nickolas S. Tabraue, BLFR’s CEO, interim CFO & Director comments with, “Farmies, Inc. is the perfect name to brand us, its short, simple...

Former Victoria’s Secret and Kohl’s leaders join the company’s Marketing and Experience and Global Consumer Tax teams KANSAS CITY, Mo., Sept. 21, 2022 (GLOBE NEWSWIRE) — H&R Block (NYSE: HRB) has named two new vice presidents to further accelerate client experience and the company’s long-term growth and transformation strategy. Chris Linderwell has been named Vice President of Consumer Tax Products, and Mike Halvorsen is the company’s new Vice President of Client Experience. The Block Horizons 2025 company growth and transformation strategy is built to continually evolve and meet the needs of customers, communities, associates and shareholders. The strategy focuses on expanded small business services, expert tax solutions for all filers’ needs and financial options that ease consumers’ burden and provide financial confidence. Chris...

Company Relocates to Charlotte, North Carolina Charlotte, NC, Sept. 21, 2022 (GLOBE NEWSWIRE) — Branded Legacy, Inc. (OTCQB: BLEG), a holding company focused on the commercial development of cannabinoid-infused products from CBD topicals and tinctures to edibles is pleased to announce it has moved its corporate office to Charlotte, North Carolina.Branded Legacy, Inc. has officially moved its corporate headquarters to Charlotte North Carolina. The new corporate address is 227 W 4th Street, Unit 108, Charlotte, NC 28202. The move was finalized on September 1, 2022. With Chairman, Brandon Spikes and CEO, Jermain Strong both residing in the Charlotte area, this move was important for the growth of the Company. Brandon Spikes, chairman of Branded Legacy, Inc., stated, “We are excited to have our offices in Charlotte now. This is where...

BERKELEY HEIGHTS, N.J., Sept. 21, 2022 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced that management will participate in Ladenburg Thalmann’s 2022 Healthcare Conference on September 29, 2022 at the Sofitel New York.Event: Ladenburg Thalmann 2022 Healthcare ConferenceDate: Thursday, September 29, 2022Time/location: 9:30am ET, Track 2, St Germain IIIFormat: Fireside Chat PresentationWebcast: LinkAbout Cyclacel Pharmaceuticals, Inc. Cyclacel is a clinical-stage, biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation and mitosis biology. The transcriptional regulation...

The Battleground Office building is the 4th BIP development to install SemaConnect charging stations GREENSBORO, N.C., Sept. 21, 2022 (GLOBE NEWSWIRE) — SemaConnect, a Blink Charging Co. (Nasdaq: BLNK, BLNKW) and leading provider of electric vehicle (EV) charging solutions to the North American commercial, residential, and fleet market, announces its newest installation with Brown Investment Properties (BIP) at the new Battleground Office Building in Greensboro, North Carolina. The four new SemaConnect charging stations at the property are open to all employees and tenants working at the building. The Battleground Office Building, located at 1007 Battleground Avenue is Brown Investment Properties & Windsor Companies’ new corporate headquarters and the fourth property for BIP to install SemaConnect EV charging stations. The...

Live video webcast with moderated roundtable between members of the AIM ImmunoTech Management Team and Key Opinion Leaders Dr. Charles Lapp of Hunter-Hopkins Center and Dr. Daniel Peterson of Sierra Internal Medicine on Wednesday, September 28th at 3:00 PM ET OCALA, Fla., Sept. 21, 2022 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE: American AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus, today announced that it will participate in the Virtual Investor Long COVID Event on Wednesday, September 28, 2022 at 3:00 PM ET. As part of the virtual event, Thomas K. Equels, MS JD, Chief Executive Officer of AIM ImmunoTech, will be joined by...

Announces Private Placement for Gross Proceeds Up To $1 MillionFigure 1: Prospect Generator Model The prospect generator model is a shareholder-focused model which aims to protect investors from excessive dilution associated with frequent equity financings.Not for distribution to United States newswire services or for release, publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. VANCOUVER, British Columbia, Sept. 21, 2022 (GLOBE NEWSWIRE) — Latin Metals Inc. (“Latin Metals” or the “Company”) – (TSXV: LMS) (OTCQB: LMSQF) provides a corporate update and announces a non-brokered private placement for gross proceeds of up to $1 million. Corporate Update The Company’s development of a prospect generator business model is continuing to advance, with option agreements...

Vilnius, Lithuania, Sept. 21, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Trend Innovations Holding Inc. (OTCQB: TREN) is a company specializing in innovative technologies using artificial intelligence. One of the company’s key projects is the Thy News application. Thy News is a mobile application that is an aggregator of news articles. It collects news from a variety of sources and provides users with a convenient issue. This is convenient and practical for users. The user is not limited to preset sources, but is offered various ways to personalize the service. Thy News meets the basic criteria of a news aggregator. Its software product collects media content, stores it in its own database and processes it. Aggregation technology helps to integrate many websites into a single page that can only display new or updated...

BOSTON, Sept. 21, 2022 (GLOBE NEWSWIRE) — AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer, today announced that Michael Bailey, president and chief executive officer, will participate in a panel discussion at the Cantor Fitzgerald Oncology & HemOnc Conference. The panel titled “Building Combinations: What are the Novel Ideas?” will be held on Wednesday, September 28th, at 10:40 a.m. eastern time. If you are interested in arranging a 1×1 meeting at the conference, please contact your Cantor representative. For more details, please see the Calendar of Events section of AVEO Oncology’s corporate website. About AVEO Pharmaceuticals, Inc. AVEO is a commercial stage, oncology-focused biopharmaceutical...

First patient achieved a confirmed partial response with 51.2% tumor regression with TCR-T cell persistence ongoing at 3 months post infusion Sleeping Beauty TCR-T cell therapy had a manageable safety profile with no dose limiting toxicities observed Data to be presented on Friday, September 30 at 9:00am ET in a proffered presentation at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy ConferenceHOUSTON, Sept. 21, 2022 (GLOBE NEWSWIRE) — Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company, today announced early clinical data from the first patient in its ongoing TCR-T Library Phase 1/2 trial. The data will be presented during a proffered talk at the CRI-ENCI-AACR Sixth International Cancer Immunotherapy Conference (CICON) being held in New York,...